Neurasignal, INC.
Doing business as Neurasignal
At a glance
Employees1-19
In business sinceNot reported
HeadquartersLos Angeles, CA
US patents14
SAM.gov UEIZN1SKCKZ1VM3
CAGE code9P5V1
Incorporated inDE
- NG2 Classic Ultrasound
- NG View
- robotics
- Transcranial Doppler ultrasound
- hemodynamic monitoring
- emboli monitoring
- PFO detection
- stroke care
- clinical trials
- webinars
Named on the company’s own website, read JUL 29, 2026
What they make
Diagnostic Ultrasonic Transducer, RoboticSystem, Imaging, Pulsed Doppler, UltrasonicTransducer, Ultrasonic, Diagnostic
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
14 US patents granted 2023–2025, 14 of them in the five years to SEP 2025.
Medical technology 14
- Integrated probe structureUS 12,390,191 · granted AUG 19, 2025
- Dynamic headset apparatusUS 12,370,110 · granted JUL 29, 2025
- System and method of generating image of vascular flow networkUS 12,343,195 · granted JUL 1, 2025
- System and method of monitoring ultrasound testsUS 12,343,194 · granted JUL 1, 2025
- Systems and methods for modular headset systemUS 12,285,287 · granted APR 29, 2025
Newest 5 shown · Granted to Neurasignal, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neurasignal, INC. | Los Angeles | CA | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.